Latest Cancer pain Stories
FLORHAM PARK, N.J., March 30, 2015 /PRNewswire/ -- Naldemedine, an investigational peripherally acting mu-opioid receptor antagonist (PAMORA) under development by Shionogi & Co., Ltd., met
Myoscience announced today that Dr.
Comprehensive market research report “Moderate to Severe Pain: Novel Abuse Deterrent Formulation Technologies and Emergence of Novel Mechanisms in the Management of Pain” elaborated by MP
Dog with bone cancer jumps for joy over new treatment that made him pain-free after one dose! SAN DIEGO, Oct.
LifeScienceIndustryResearch.com adds “United States – Pain Management Therapeutics Patients & Market Analysis” Latest Report to its store. Dallas,
Transparency Market Research has announced the addition of the "Pain Management Therapeutics Market: Global Industry Analysis, Size, Share, Growth and Forecast 2012 - 2018" report to
Nevada has a new leading pain management center specializing in the treatment for chronic and acute pain conditions. Las Vegas, NV (PRWEB) June 18, 2014
When cancer progresses and spreads to the bone, patients often suffer debilitating pain.
-- Clinically meaningful improvement in quality of life with single injection of resiniferatoxin SAN DIEGO, April 4, 2014 /PRNewswire/ -- Sorrento Therapeutics,
- a slit in a tire to drain away surface water and improve traction.